@alittlemorewine @cyrusofeden Is it your evening routine standup, where all of you are off your screens, reading book passages to each other, doing some calming breath work, and preparing for restful sleep

@mashadrokova I’m just minding my own business

@calleymeans @TrueMedPayments @jwmares We’ve got work to do 🤝

It has come to my attention that many of you think I don’t have fun.

This video was shot at 1:50 am while @Grimezsz was electrifying.

I slept from 8-10 pm, getting 90 min of brain restorative deep sleep; back in bed at 3 am to get 6 more hours.

imho, now is the first opening in 2,000 years for a new, global ideology to emerge.

Don’t Die is the dark horse.

ty @micsolana and Peter Thiel for assembling @hereticon

Sources:

1.
2.
3.
4.
5.

The Ozempic advantage in preventing Alzheimer's disease seems to be independent of its weight reduction effect, as the Alzheimer's disease risk reduction extended to both obese and non-obese patients on Ozempic as compared to other type 2 diabetes medications.

Unlike between…

This shows potential for Ozempic and other GLP1 receptor agonists as potential longevity drugs beyond their role as diabetes and obesity medication, and warrants more credibility to earlier claims that focused only on obese patients. Ref (5)

Ozempic had better Alzheimer's disease protective advantage in women, and in the special case of SGLT2-inhibitors, the Ozempic advantage was exclusive in women, with SGLT2 inhibitors outperforming Ozempic slightly by 14% in Alzheimer's disease.

This is very intriguing in light…